Trial intelligence / Profile preview

Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS

NCT07310927Phase 3Completed

Sponsor
CMH Lahore Medical College and Institute of Dentistry
Start
Apr 2025
Primary completion
Apr 2026
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium trisilicate in gastroesophageal reflux disease (GERD), sponsored by CMH Lahore Medical College and Institute of Dentistry. Started Apr 2025; status: completed.

02

Drugs

magnesium trisilicate
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT07310927.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07310927.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call